Tumor xenografts from H2023 cells expressing EGFP, ARAF-WT, and ARAF p.S214C in immunodeficient Nu/J mice were also generated, and their in vivo tumorigenicity and sorafenib response were compared. The gene discussed is ARAF; the disease is neoplasm.